(2022). Incidence and pattern of mycophenolate discontinuation associated with abnormal monitoring blood-test results: cohort study using data from the Clinical Practice Research Datalink Aurum. Rheumatol Adv Pract, 6, rkac046. http://doi.org/10.1093/rap/rkac046.
(2021). What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keab254.
(2021). Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood-tests during long-term treatment: cohort study using data from Clinical Practice Research Datalink Gold and Aurum. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keab790.